Patent · US Expired

5-oxime avermectin derivatives

US5015630A · kind A · utility

12Cited by
9References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 19, 1989
Grant dateMay 14, 1991
Priority date
Expiry dateJan 19, 2009

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H17/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel avermectin derivatives are disclosed, wherein the 5-hydroxy group is replaced by an oxime group. The avermectin-5-oximes can further be derivatized at the 4"- or 4'-positions as amino, substituted amino, acylhydrazone, semicarbazone, or substituted semicarbazone analogues. The avermectin-5-oximes are prepared by the oxidation of the 5-hydroxy compounds with manganese dioxide or with pyridinium dichromate to the known 5-oxo analogues, and these are then reacted with a hydroxylamine salt. The new compounds are potent anti-parasitic agents, in particular, the compounds are anthelmintic, insecticidal and acaricidal agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.